WELL Health Technologies Corp.

... ... Thank you. . . . . . . Thank you.

Good afternoon, ladies and gentlemen, and welcome to the Well Health Technologies Corp. 4th Quarter 2025 and Esquire 2025 conference call. At this time, our lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you need assistance, please press star 0 for the operator. This call is being recorded on Thursday, March 19, 2026. I would now like to turn the conference over to Pardip Sangha, Investor Relations. Please go ahead.

Thank you, Operator, and welcome everyone to Well Health's fiscal fourth quarter and year-end 2025 financial results conference call for the period ended December 31st, 2025. Joining me on the call today are Hamed Shabazi, Chairman and CEO, and Eva Fong, the company's CFO. I trust that everyone has received a copy of our financial results press release that was issued earlier today. Portions of today's call, other than historical performance, include statements of forward-looking information within the meaning of applicable securities laws including future-oriented financial information and financial outlook information. These forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other factors, many of which are outside of wealth control that may cause the actual results, performance, or achievements of wealth to differ materially from the anticipated results, performance, or achievements implied by such forward-looking statements. These factors are further outlined in today's press release and in our management discussion and analysis. We provide forward-looking statements solely for the purpose of providing information about management's current expectations and plans relating to the future. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions, assumptions, or circumstances on which any such statement is based, except if it is required by law. We may use terms such as normalized revenue, adjusted gross profit, adjusted gross margin, normalized and adjusted EBITDA, adjusted EBITDA margin, shareholder EBITDA, adjusted net income, and adjusted free cash flow on this conference call, all of which are non-GAAP and non-IRFRS measures. For more information on how to define these terms, please refer to the definitions set out in today's press release and in our manager discussion and analysis. The company believes that adjusted EBIT is a meaningful financial metric as it measures cash generated from operations which the company can use to fund capital requirements, service future interests, and principal debt payments, and fund future growth initiatives. Adjusted EBIT should not be construed as an alternative to net income or loss determined in accordance with IFRS. And with that, let me turn the call over to Mr. Hamed Shabazi, Chairman and CEO. Hamed?